OPN has been reported as a diagnostic marker in patients with breast cancers [31] and suppression of tumor derived OPN by its antisense S-oligonucleotide and siRNA has been shown to suppress the in vitro proliferation, migration, and in vivo osteolytic metastasis in nude rats [38-40]. Here, SPP1 is linked to breast cancer.